A new study published in Value in Health, co-authored by CEVR’s Peter Neumann, shows no evidence that the use of quality-adjusted life years (QALYs) disadvantages people with disabilities. The research shows that results vary depending on the treatment and condition, with several analyses finding equal or greater QALY gains among patients with more severe disease. Read the full article below for a closer look at the findings and methodology.
